All In Biotech

Drug Trial Radar · NCT06516965

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 346 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

346

Actual

Start

Oct 10, 2024

Primary completion

Sep 28, 2026

Study completion May 3, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Jul 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Conditions

  • Prurigo Nodularis

Interventions

  • PovorcitinibDrug

    Oral Tablet

  • PlaceboDrug

    Oral Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants achieving Itch NRS4 and IGA-CPG-S-TS at Week 24Time frame: Week 24

Locations

119 sites in 11 countries. Site status is shown where the registry gives one.

  • Medical Dermatology Specialists Phoenix

    Phoenix, Arizona

  • Investigate Md

    Scottsdale, Arizona

  • First Oc Dermatology Research Inc

    Fountain Valley, California

  • Clinical Science Institute Clinical Research Specialists Inc

    Santa Monica, California

  • Center For Clinical and Cosmetic Research

    Aventura, Florida

  • Schweiger Dermatology

    Boca Raton, Florida

  • Direct Helpers Research Center

    Hialeah, Florida

  • Skin Care Research, Llc

    Hollywood, Florida

  • Ziaderm Research, Llc

    Miami, Florida

  • Nodal Medical Center, Llc

    Tampa, Florida

  • Trueblue Clinical Research Moore Clinical Research, Inc McR Tampa Clinic Location

    Tampa, Florida

  • Dermatology Specialists Research

    Louisville, Kentucky

  • University of Maryland School of Medicine

    Baltimore, Maryland

  • Dermatology Associates Pc

    Rockville, Maryland

  • Metro Boston Clinical Partners

    Brighton, Massachusetts

  • Fivenson Dermatology

    Ann Arbor, Michigan

  • Henry Ford Health System

    Detroit, Michigan

  • Michigan Dermatology Institute

    Waterford, Michigan

  • Allcutis Research, Llc

    Portsmouth, New Hampshire

  • Schweiger Dermatology

    Hackensack, New Jersey

  • OPTISKIN

    New York, New York

  • University of Cincinnati Cancer Institute

    Cincinnati, Ohio

  • Central Sooner Research

    Oklahoma City, Oklahoma

  • Paddington Testing Co Inc

    Philadelphia, Pennsylvania

  • Yardley Dermatology Associates

    Yardley, Pennsylvania

  • Modern Research Associates Pllc

    Dallas, Texas

  • University of Utah Midvalley Dermatology

    Murray, Utah

  • Aesthetic General Dermatology of Seattle

    Burien, Washington

  • Fremantle Dermatology

    Fremantle, Australia

  • Novatrials

    Charlestown, New South Wales, Australia

  • Premier Specialists Pty Ltd

    Kogarah, New South Wales, Australia

  • Skin & Cancer Foundation Australia

    Sydney, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Veracity Clinical Research Pty Ltd

    Woolloongabba, Queensland, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • Az Sint-Jan Brugge Av

    Bruges, Belgium

  • Universitair Ziekenhuis Gent (Uz Gent)

    Ghent, Belgium

  • Grand Hopital de Charleroi - Site Imtr

    Gilly, Belgium

  • Centre Hospitalier Universitaire (Chu) de Liege - Domaine Universitaire Du Sart Tilman

    Liège, Belgium

  • Universite Catholique de Louvain (Ucl) - Cliniques Universitaires Saint-Luc

    Woluwe-Saint-Lambert, Belgium

Showing 40 of 119 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.